Literature DB >> 7623729

Childhood acute lymphoblastic leukemia in India: an approach to management in a three-tier society.

M Chandy1.   

Abstract

Within a population of 882 million, six thousand children will develop acute lymphoblastic leukemia each year in India. These children come from three socio-economic backgrounds: Profile I (70%) being extremely poor who cannot afford any treatment unless it is provided free, Profile II (25%) from the middle class, and Profile III (5%) who can afford to have the best possible treatment. Current protocols for childhood ALL range from simple low-cost regimes like UKALL VIII, intermediate intensity regimes like BFM 76/79, and aggressive regimes aimed at increasing cure rates in the high risk groups. Since state resources are limited, the pediatric oncologist in India has to decide on the appropriate treatment protocol for the individual child in each of these profiles. This paper suggests an approach to managing childhood ALL in developing countries like India.

Entities:  

Mesh:

Year:  1995        PMID: 7623729     DOI: 10.1002/mpo.2950250307

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  6 in total

1.  Childhood cancer--challenges and opportunities.

Authors:  L S Arya
Journal:  Indian J Pediatr       Date:  2003-02       Impact factor: 1.967

2.  Lympho-hemopoietic malignancies in India.

Authors:  Manisha Bhutani; Amish Vora; Lalit Kumar; Vinod Kochupillai
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

Review 3.  International collaboration on childhood leukemia.

Authors:  Ching-Hon Pui; Raul C Ribeiro
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

4.  Health-related quality of life among children with cancer in Hyderabad, India.

Authors:  Susmitha Chirivella; Senthil Rajappa; Sudha Sinha; Tim Eden; Ronald D Barr
Journal:  Indian J Pediatr       Date:  2009-12       Impact factor: 1.967

5.  Correlation of Day 8 Steroid Response with Bone Marrow Status Measured on Days 14 and 35, in Patients with Acute Lymphoblastic Leukemia Being Treated with BFM Protocol.

Authors:  Girish Kamat; Kannan Subramanian; Shashikant Apte
Journal:  Indian J Hematol Blood Transfus       Date:  2019-04-08       Impact factor: 0.900

6.  Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol.

Authors:  Venkatraman Radhakrishnan; Sumant Gupta; Prasanth Ganesan; Rejiv Rajendranath; Trivadi S Ganesan; Kamalalayan Raghavan Rajalekshmy; Tenali Gnana Sagar
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.